已收盘 12-19 16:00:00 美东时间
-2.270
-1.25%
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
12-18 10:54
Argus Research analyst Kevin Heal maintains MarketAxess Holdings (NASDAQ:MKTX) with a Buy and lowers the price target from $212 to $205.
12-17 21:46
MarketAxess (NASDAQ:MKTX) announced on Tuesday that it has authorized the repurchase of up to $400M of additional shares of common stock. The new authorization, combined with the $105M previously anno...
12-09 21:21
The latest announcement is out from Marketaxess Holdings ( ($MKTX) ). On Decemb...
12-09 20:59
U.S. stocks were lower, with the Dow Jones falling around 0.1% on Thursday. Sha...
12-04 23:12
今日重点评级关注:Ascendiant Capital:维持Aclarion"买入"评级,目标价从22美元升至23美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从24美元升至26美元
11-21 15:50
Morgan Stanley analyst Michael Cyprys downgrades MarketAxess Holdings (NASDAQ:MKTX) from Overweight to Equal-Weight and lowers the price target from $247 to $209.
11-20 23:18
今日重点评级关注:Guggenheim:维持InflaRx"买入"评级,目标价从10美元升至22美元;巴克莱:维持Tandem糖尿病护理"超配"评级,目标价从51美元升至55美元
11-11 10:49
Barclays analyst Benjamin Budish maintains MarketAxess Holdings (NASDAQ:MKTX) with a Equal-Weight and raises the price target from $186 to $188.
11-11 02:49
Risk-off sentiment dominated Wall Street on Friday, with selling pressure in AI-linked names intensifying and pushing technology stocks toward their worst week since April.
11-08 01:45